Literature DB >> 6272905

Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients.

S H Pincus, W R Schooley, A M DiNapoli, S Broder.   

Abstract

Eosinophils, which may be associated with allergic, parasitic, or neoplastic disease, have a potent oxidative burst that may be activated by particulate or soluble stimuli. Eosinophils from normal persons and patients with hypereosinophilia were compared with respect to their ability to produce the active oxygen product, superoxide anion. Normal eosinophils produced large amounts of superoxide anion under resting conditions (0.53 +/- 0.15 nmoles cyto-c/10(5) eos/hr) and when stimulated by preopsonized zymosan (0.85 +/0 1.10 nmoles cyto-c/10(5) eos/hr) or phorbol myristate acetate (PMA) (2.38 +/- 0.46 nmoles cyto-c/10(5) eos/hr). Considerable variation was observed in superoxide production by eosinophils from patients with hypereosinophilia. Eosinophils from a group of four patients with hypereosinophilia associated with neoplastic disease produced less superoxide anion than normal eosinophils when stimulated by preopsonized zymosan or PMA (p less than or equal to 0.05). Eosinophils from a group of 5 patients with other causes of hypereosinophilia produced more superoxide anion than normal eosinophils when stimulated by PMA (p less than or equal to 0.01). These studies demonstrate metabolic heterogeneity of eosinophils from patients with hypereosinophilia, and further emphasize that normal eosinophils and eosinophils from hypereosinophilic patients are not functionally equivalent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272905

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure.

Authors:  J Yang; A Torio; R B Donoff; G T Gallagher; R Egan; P F Weller; D T Wong
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

2.  Oxidative requirement for degranulation of human peripheral blood eosinophils.

Authors:  P Baskar; S H Pincus
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

3.  Purification of eosinophils from normal human blood, preparation of eosinoplasts and characterization of their functional response to various stimuli.

Authors:  M Yazdanbakhsh; C M Eckmann; M De Boer; D Roos
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

4.  Immunocytochemical localization of two peroxisomal enzymes of lipid beta-oxidation in specific granules of rat eosinophils.

Authors:  S Yokota; W Deimann; T Hashimoto; H D Fahimi
Journal:  Histochemistry       Date:  1983

5.  Specific granules of rat eosinophils contain peroxisomal acyl-CoA oxidase: possible involvement in production of H2O2.

Authors:  S Yokota; W Deimann; T Hashimoto; H D Fahimi
Journal:  Histochem J       Date:  1984-05

6.  An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations.

Authors:  S M Andrew; B Jasani
Journal:  Histochem J       Date:  1987-08

7.  Hypereosinophilic syndrome in cats: a report of three cases.

Authors:  S A McEwen; V E Valli; T J Hulland
Journal:  Can J Comp Med       Date:  1985-07

8.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Bactericidal action of eosinophils from normal human blood.

Authors:  M Yazdanbakhsh; C M Eckmann; A A Bot; D Roos
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

10.  The cardiotoxicity of eosinophils.

Authors:  C J Spry; P C Tai; J Davies
Journal:  Postgrad Med J       Date:  1983-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.